Pub­lic Cit­i­zen sues FDA over cit­i­zen pe­ti­tion on SS­RI sex­u­al side ef­fects la­bel­ing

The FDA should re­quire drug­mak­ers to warn pa­tients of po­ten­tial long-term sex­u­al side ef­fects from a cer­tain class of an­ti­de­pres­sants, the con­sumer ad­vo­ca­cy group Pub­lic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER